Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD
Recruiting · NCT07523880 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-Omics-Based Novel Thrombosis and Bleeding Markers and Risk Model for CHD | Arterial Occlusive Diseases, Embolism and Thrombosis, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-04-13 | NCT07523880 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Central China Fuwai Hospital of Zhengzhou University | 10 |
| The General Hospital of Northern Theater Command | 19 |
| Xueyan Zhao | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuwai Central China Cardiovascular Hospital | Zhengzhou | China | 11 |
| Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 3 |
| General Hospital of Northern Theater Command of Chinese People's Liberation Army | Shenyang | China | 1 |